Telehealth

Preliminary data from a randomized trial suggests a personalized medicine approach can reverse cognitive decline, offering a glimmer of hope beyond slowing the disease.

Speediance's new partnership with ATHX signals a major shift, moving advanced digital training from the living room to the world of competitive fitness.

Light AI's smartphone diagnostic tool enters a crucial New Zealand study, but can its innovative tech overcome financial pressures and regulatory hurdles?

The FDA's approval of a new Type 1 Diabetes therapy is a landmark. But the real story is the collaborative engine clearing the path for future breakthroughs.

BetterAge's new executive team signals a potent strategy: combining deep industry partnerships with advanced AI to scale in the competitive elder care market.

A silent productivity drain is costing businesses dearly. Over half the workforce aged 40-60 is managing elder care, and the financial and career toll is immense.

As biopharma navigates a maze of privacy laws and AI, a new platform aims to centralize patient consent, turning a compliance nightmare into a bridge for trust.

The online therapy market is booming, attracting institutional capital. We dissect the growth drivers, regulatory risks, and evolving business models.

A small-town medical spa is investing in cutting-edge tech for body, bladder, and brain. Is this the future of healthcare or a high-stakes gamble?

New clinical trial results for XWRAP® show a significant leap in healing diabetic ulcers, positioning Applied Biologics as a formidable player in a challenging field.

Elevance Health is deploying a suite of AI-driven tools to manage chronic illness. Is this the future of healthcare or just a new set of digital hurdles?

While a local Indiana story highlights the human cost of caregiver burnout, it unveils a massive, underserved market poised for explosive growth and fintech innovation.

With projections of $22.7M from four new supplements, Cosmos Health is betting big on the US. But can its 'science-driven' platform deliver in a crowded market?

A landmark study proves drones can safely transport human kidneys, a breakthrough that could slash wait times and save lives. But can we clear the regulatory hurdles?

Coca-Cola's smartwater and fitness brand Pvolve are using Jennifer Aniston not just as a face, but as the central hub for a new integrated wellness strategy.

As nurses and for-profit homes enter bitter arbitration, the standoff exposes a critical flaw in long-term care: a business model at odds with its mission.

Lexeo Therapeutics finalizes a pivotal trial for its Friedreich ataxia gene therapy, leveraging a novel trial design and accelerated FDA pathway.

BMO's new partnership with non-profit GreenShield isn't just another insurance product. It's a strategic move to merge coverage and care, challenging the market.

For 20 years, Montreal's Segal Cancer Centre has quietly built a world-class innovation engine. We dissect its unique model where research, care, and funding converge.

A new pact between BioSTL and the UK's NHS is set to make St. Louis a prime U.S. launchpad for health tech, turning global innovation into local impact.